Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)


Wir halten Sie auf dem Laufenden! Wenn Sie Fragen zu unseren Pressemitteilungen haben, können Sie uns gerne über das Kontaktformular der Website kontaktieren. Bleiben Sie über die neuesten Nachrichten unseres Unternehmens auf dem Laufenden:

Brachytherapy expansion of Argentinean Mevaterapia supported by Eckert & Ziegler BEBIG Co-60 MultiSource® afterloader

Seneffe, Belgium, August 19, 2015, Eckert & Ziegler BEBIG has installed its first MultiSource® afterloader in Argentina. The installation was carried out in the medical center Mevaterapia which is the radiotherapy department of the Hospital Italiano de Buenos Aires.

Mevaterapia is a full care radiotherapy center that offers CT, IMRT, superficial radiotherapy, CNS, total body irradiation, photon and electron therapy and LDR prostate brachytherapy. Dr. Federico Diaz, Deputy Medical Director and Radiotherapist at Mevaterapia states: "With MultiSource®, we plan to expand the yearly amount of gynecological brachytherapy treatments to 260 in 2015 and continuously more over the next years. In the near future, we also plan to offer dermatological as well as rectum, anus, sarcoma and especially breast brachytherapy to treat the cancer with the highest incidence among females in Argentina.

The decision to select cobalt-60 over iridium-192, although both isotope types are offered for all Eckert & Ziegler BEBIG afterloader types, was due in large part to time savings in performing quality assurance checks after each source exchange and in import logistics. Cobalt-60 has a longer half-life in comparison to iridium-192, lasting more than five years compared to only three month for iridium-192. Additionally, Dr. Diaz points out that the 3D treatment planning options together with the Eckert & Ziegler BEBIG CT and MR compatible applicators played a significant role in the decision for MultiSource® and the HDR treatment planning system SagiPlan®.

For more information on MultiSource® and SagiPlan®, please visit:


About Eckert & Ziegler BEBIG
Contributing to saving lives!

Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treat¬ment of cancer using brachytherapy. The company headquarters are in Belgium, with production facilities in Germany and in the USA, as well as subsidiaries throughout Europe, the USA, India and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents, to support the international marketing and distribution of its product line. The company's products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists.
Eckert & Ziegler BEBIG employs approximately 200 people. The company has been listed on the Euronext stock exchange since April 1997.

Annica Witt
Marketing Communication Manager